Primary Care Companion
PPP
Login  

This entire article is available in Full Text to registered users.

 

The article you requested is

Aripiprazole Worsens Psychosis: A Case Report

Prim Care Companion J Clin Psychiatry 2006;8(6):380-381 [letter]
10.4088/PCC.v08n0611e

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Aripiprazole is a second-generation antipsychotic medication with a unique mechanism of action. It acts as a functional antagonist or functional agonist at dopamine and serotonin receptors, depending upon the level of the relevant neurotransmitter in the immediate environment, and for this reason, it is known as a dopamine-serotonin system stabilizer.1 Due to the partial-agonist D2 receptor activity of aripiprazole, it has been suggested to worsen psychosis.2 We report a case in which the unique mechanism of action of aripiprazole probably contributed to relapse of psychotic symptoms.​